|
VRDN Viridian Therapeutics Incde 1590750 |
| Balance Sheet |
|
Current Assets
|
767,357,000 |
|
Assets
|
771,900,000 |
|
Current Liabilities
|
41,364,000 |
|
Liabilities
|
64,404,000 |
|
Equity
|
707,496,000 |
|
Shares Out
|
63,890,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-158,987,000 |
|
Investing Cash Flow
|
-165,736,000 |
| Market Analysis |
Market Cap
|
1,622,358,450 |
|
Price
|
18.13 |
|
BVPS
|
11.07 |
|
PB
|
1.65 |
|
EPS
|
-4.25 |
|
PS
|
4716.16 |
|
FCF
|
-324,723,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VRDN documents filed with the SEC.
VRDN Filings
Clear
